Layne Norton
Layne Norton holds a Ph.D. in Nutritional Sciences and is a professional bodybuilder and powerlifter. His published research focuses on sports nutrition, protein metabolism, and resistance training, specifically examining the effects of dietary protein and leucine on muscle protein synthesis, metabolic adaptation to weight loss, and nutritional supplementation for athletic performance.
107 claims checked on air: 13 context 5 contradicted 12 overstated 67 supported 10 unverified
What they said on air - supported
A 1992 New England Journal of Medicine study on self-reported diet-resistant obese subjects found they reported consuming 1,200 calories per day but actually consumed over 1,800 calories and overreported physical activity by 47%.
"There's a very classic study in 1992, the New England Journal of Medicine. They had people who self-reportedly were weight-loss resistant. So these people claimed that they were eating 1,200 calories a day... when they tracked their intake, what they found was they reported 1,200 calories a day, but on average they were consuming about just over 1,800. And they also overreported their physical activity by 47%." (said at 0:15:26)
The speaker accurately describes the landmark 1992 study published in the New England Journal of Medicine by Lichtman et al. (PMID 1454084). The study evaluated obese subjects with self-reported diet resistance who claimed to consume under 1,200 kcal/day. The researchers found that subjects underreported actual caloric intake by an average of 47 ± 16% (meaning actual intake was substantially higher) and overreported physical activity by 51 ± 75%, rather than having abnormal metabolic rates or thermogenesis.
Semaglutide (Ozempic) does not increase metabolic rate; it functions as a powerful appetite suppressant.
"Ozempic is not going to help because it doesn't increase your metabolic rate. It is a very powerful appetite suppressant." (said at 0:16:20)
Randomized controlled trial evidence demonstrates that semaglutide induces weight loss through appetite suppression and reduced energy intake, without increasing resting metabolic rate. In a double-blind, placebo-controlled crossover study assessing the mechanisms of semaglutide, treatment resulted in a 24% reduction in total daily ad libitum energy intake alongside improved appetite suppression scores, decreased hunger, and reduced food cravings. Resting metabolic rate, when adjusted for lean body mass, showed no difference between semaglutide and placebo.
- supports: Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food pre… (Diabetes, obesity & metabolism 2017) · cited 670x in the literature
"Fasting overall appetite suppression scores were improved with semaglutide vs placebo, while nausea ratings were similar. Semaglutide was associated with less hunger and food cravings, better control of eating and a lower preference for high-fat foods. Resting metabolic rate, adjusted for lean body mass, did not differ between treatments." (abstract, results, passage verified)
pubmedfull study (doi)
Lean body mass accounts for approximately 70% to 80% of the variance in basal metabolic rate and total energy expenditure.
"found that basically people's lean body mass explained about 70 to 80% of the variance in BMR and total energy expenditure. You can almost draw like a straight line through it." (said at 0:16:35)
The claim accurately reflects standard physiological literature. Fat-free mass (or lean body mass) is well-established as the primary determinant of basal metabolic rate (BMR) / resting energy expenditure (REE) and a major driver of total energy expenditure (TEE), consistently accounting for approximately 70% to 80% of the interindividual variance in metabolic rate across diverse human cohorts.
Per unit of mass, skeletal muscle has a relatively low metabolic rate compared to other lean tissues like the liver and gut.
"skeletal muscle doesn't have a super high energy expenditure for a lean tissue. It's actually one of the slowest, if not the slowest, like liver and gut tissues have a much higher metabolic rate." (said at 0:17:45)
The claim accurately reflects human physiological and body composition research. Resting energy expenditure (REE) is determined by individual organ and tissue masses multiplied by their specific metabolic rates. Established literature (e.g., Elia 1992, Heymsfield/Wang models) demonstrates that per unit of mass at rest, skeletal muscle has one of the lowest specific metabolic rates among lean tissues (approximately 13 kcal/kg/day or ~54 kJ/kg/day), whereas internal organs such as the liver (~200 kcal/kg/day), gut/intestines, brain (~240 kcal/kg/day), and heart (~400 kcal/kg/day) have markedly higher metabolic rates per unit mass.
Research on vigorous intermittent lifestyle physical activity (VILPA) showed that 4 minutes of cumulative vigorous activity per day was associated with a 20% reduction in cancer risk, and 10 minutes was associated with a 30% reduction.
"4 minutes vigorous activity per day reduced cancer risk by I believe 20%, okay? And then if you got up to 10 minutes, I think it was 30%, right?" (said at 0:21:10)
A prospective cohort study of 22,398 nonexercising adults in the UK Biobank using wrist-worn accelerometers (Stamatakis et al., 2023) evaluated vigorous intermittent lifestyle physical activity (VILPA) and cancer incidence over a mean follow-up of 6.7 years. The authors found that a median of 4.5 minutes of daily VILPA (in bouts of up to 1 minute) was associated with a 20% reduction in total cancer risk (hazard ratio 0.80, 95% CI 0.69–0.92) and a 31% reduction in physical activity-related cancer risk (hazard ratio 0.69, 95% CI 0.55–0.86) compared to no VILPA, with dose-dependent reductions seen across durations. Because this is observational evidence from accelerometer data, certainty is rated low due to potential residual confounding.
A randomized controlled trial found that two 25-minute resistance training sessions per week for 8 weeks yielded an effect size of 1.7 in reducing major depressive disorder symptoms.
"There was actually a recent randomized controlled trial where they took people with major—or men with major depressive disorder or generalized anxiety disorder, and they had them do two 25-minute sessions of resistance training a week, that's it. And it was for eight weeks, and the improvements in major depressive disorder and generalized anxiety disorder—the effect size for major depressive disorder was 1.7." (said at 0:21:55)
A 2023 randomized controlled trial by Gordon et al. evaluated an 8-week, twice-weekly guidelines-based resistance exercise training intervention compared to a wait-list control in 55 young adults with and without analogue (subclinical) major depressive disorder (AMDD) and generalized anxiety disorder (AGAD). In the subsample with analogue major depressive disorder, resistance training produced a statistically significant reduction in depressive symptoms with a Hedges' d effect size of 1.71 (95% CI: 0.96 to 2.46). Note that the study sample included both men and women (36 females, 19 males) and assessed analogue/subclinical diagnoses rather than formal clinical diagnoses.
Muscle fibers are recruited in order according to the size principle, starting from the smallest oxidative fibers up to glycolytic fibers.
"Fibers tend to be recruited in order—there's some challenge to this research, but they tend to be recruited in order from smallest oxidative up to, you know, middling kind of hybrid fibers up to your glycolytic, right?" (said at 0:33:19)
Henneman's size principle is a foundational neurophysiological concept establishing that motor units are recruited in a fixed, orderly hierarchy based on motoneuron size and activation threshold. Low-threshold motor units consisting of smaller, fatigue-resistant, slow-twitch oxidative fibers (Type I) are recruited first for low-force tasks. As greater force demands or fatigue occur, intermediate (fast oxidative-glycolytic) and larger, high-threshold, fast-twitch glycolytic motor units (Type II) are progressively recruited.
- supports: Neural control of motor output: can training change it? (Exercise and sport sciences reviews 2002) · cited 39x in the literature
"Henneman's size principle of motor unit recruitment and rate coding reduces fatigue, minimizes error in transfer of information from the nervous system, and produces smooth force output. Plasticity present at various sites of the motor system may change endurance, force, speed, or precision with training, but not the recruitment order." (abstract, passage verified)
pubmedfull study (doi) - supports: The resilience of the size principle in the organization of motor unit properties in norma… (Canadian journal of physiology and pharmacology 2004) · cited 98x in the literature
"Henneman's size principle relates the input and output properties of motoneurons and their muscle fibers to size and is the basis for size-ordered activation or recruitment of motor units during movement." (abstract, passage verified)
pubmedfull study (doi) - supports: Hierarchical control of motor units in voluntary contractions. (Journal of neurophysiology 2012) · cited 234x in the literature
"This hierarchical control scheme describes a mechanism that provides an effective economy of force generation for the earlier-recruited lower force-twitch motor units, and reduces the fatigue of later-recruited higher force-twitch motor units" (abstract, passage verified)
pubmedfull study (doi)
Maximizing muscle hypertrophy requires performing sets within a few repetitions of failure, but does not require training completely to muscular failure.
"Now, the research seems to suggest for a muscular hypertrophy, you have to get within a few reps of failure to really maximize the response, but you probably don't need to go all the way to failure." (said at 0:34:29)
Meta-analyses and meta-regressions examining resistance training proximity to failure confirm that training completely to momentary muscular failure is not required to maximize muscle hypertrophy. When sets are performed closer to failure (i.e., with fewer repetitions in reserve), hypertrophic adaptations increase compared to training far from failure, but terminating sets within a few repetitions of failure elicits muscle growth comparable to training to absolute failure.
- supports: Influence of Resistance Training Proximity-to-Failure on Skeletal Muscle Hypertrophy: A Sy… (Sports medicine (Auckland, N.Z.) 2023) · cited 64x in the literature
"Overall, our main findings suggest that (i) there is no evidence to support that resistance training performed to momentary muscular failure is superior to non-failure resistance training for muscle hypertrophy and (ii) higher velocity loss thresholds, and theoretically closer proximities-to-failure do not always elicit greater muscle hypertrophy." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Exploring the Dose-Response Relationship Between Estimated Resistance Training Proximity t… (Sports medicine (Auckland, N.Z.) 2024) · cited 55x in the literature
"in all of the best-fit models for muscle hypertrophy, the marginal slopes for estimated RIR were negative and their confidence intervals did not contain a null point estimate, indicating that changes in muscle size increased as sets were terminated closer to failure." (abstract, results, passage verified)
pubmedfull study (doi)
Meta-analyses and meta-regressions demonstrate a dose-response relationship between the number of hard resistance training sets performed and muscle hypertrophy.
"So we have several meta-analyses now and meta-regressions kind of suggesting that there's kind of a dose response between number of hard sets you do and muscular growth." (said at 0:36:00)
Multiple systematic reviews, meta-analyses, and meta-regressions of randomized resistance training trials support the existence of a dose-response relationship between weekly set volume and muscle hypertrophy. A seminal meta-regression of 15 studies (34 treatment groups) found that each additional weekly set per muscle group was associated with an increase in effect size of 0.023 for muscle hypertrophy (P = 0.002). Subsequent large-scale meta-regressions (e.g., 67 studies, 2058 participants) corroborate that muscle growth increases with weekly set volume, exhibiting a positive dose-response curve with diminishing returns at higher volumes.
A meta-regression showed that proximity to failure is linearly associated with muscle hypertrophy, whereas proximity to failure has no association with strength gains.
"he did a meta-regression looking at hypertrophy, showing that proximity to failure kind of was linearly associated with more hypertrophy. So the closer you got to failure, the more hypertrophy you got. The strength regression didn't show that. It had no association with your proximity to failure." (said at 0:42:44)
A 2024 systematic review and multilevel meta-regression by Robinson and colleagues evaluated the dose-response relationship between repetitions in reserve (proximity to failure) and both muscle hypertrophy and strength gains. The authors found that closer proximity to failure was linearly associated with greater muscle hypertrophy (negative marginal slopes for RIR where confidence intervals excluded zero). Conversely, across all best-fit models for strength outcomes, the confidence intervals contained the null point estimate, showing no meaningful association between estimated proximity to failure and strength gains.
Resistance training using machines produces equivalent muscle hypertrophy compared to training with free weights.
"and the research shows very clearly now that machines produce as much hypertrophy as free weights." (said at 0:46:19)
Systematic reviews and meta-analyses directly comparing machine-based resistance training to free-weight resistance training show no significant difference in muscle hypertrophy between modalities.
- supports: Machines and free weight exercises: a systematic review and meta-analysis comparing change… (The Journal of sports medicine and physical fitness 2022) · cited 24x in the literature
"There were no differences in the change in power (ES: -0.049 [95% CI: -0.557, 0.460]) or muscle hypertrophy (ES: -0.01 [95% CI: -0.525, 0.545]) between exercise modes." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Effect of free-weight vs. machine-based strength training on maximal strength, hypertrophy… (BMC sports science, medicine & rehabilitation 2023) · cited 31x in the literature
"However, no differences were found between modalities in direct comparison (free-weight strength vs. machine strength) for dynamic strength (SMD: 0.084, CI: -0.106, 0.273, p = 0.387), isometric strength (SMD: -0.079, CI: -0.432, 0.273, p = 0.660), countermovement jump (SMD: -0.209, CI: -0.597, 0.179, p = 0.290) and hypertrophy (SMD: -0.055, CI: -0.397, 0.287, p = 0.751)." (abstract, results, passage verified)
pubmedfull study (doi)
Partial repetitions performed specifically in the lengthened position produce similar muscle hypertrophy to full range of motion exercises.
"But when they compare partials in a lengthened position, so say if you're just doing the bottom part of a squat in a partial, which by the way sounds horrible, compared to a full range of motion, you see similar hypertrophy." (said at 0:49:21)
Randomized controlled trials evaluating resistance training range of motion show that partial repetitions performed at long muscle lengths (lengthened partials) produce muscle hypertrophy comparable to full range of motion exercises. In a multi-center randomized trial evaluating limb muscle cross-sectional area over 12 weeks, differences between full range of motion and lengthened partial training were small and statistically equivalent for both arm and thigh musculature. Similarly, within-participant randomized trials assessing upper-body muscle thickness have found equivalent hypertrophy between lengthened partials and full range of motion.
When sets are equated for proximity to failure, low-load training down to 40% of 1RM produces similar muscle hypertrophy compared to high-load training.
"when we look at equated sets in terms of proximity to failure, when they compare low-load training, and I think even down to like 40% of a one-rep max versus high-load training, they don't see differences in hypertrophy." (said at 0:52:56)
Multiple systematic reviews and meta-analyses of randomized trials demonstrate that when resistance exercise sets are equated for proximity to failure (i.e., taken to momentary muscular or volitional failure), low-load resistance training (including loads between 30% and 60% of 1RM) produces muscle hypertrophy comparable to high-load resistance training. In contrast, dynamic maximal strength gains (1RM) consistently favor high-load training.
- supports: Strength and Hypertrophy Adaptations Between Low- vs. High-Load Resistance Training: A Sys… (Journal of strength and conditioning research 2017) · cited 850x in the literature
"Changes in measures of muscle hypertrophy were similar between conditions. The findings indicate that maximal strength benefits are obtained from the use of heavy loads while muscle hypertrophy can be equally achieved across a spectrum of loading ranges." (abstract, results and conclusions, passage verified)
pubmedfull study (doi) - supports: Resistance Training Load Effects on Muscle Hypertrophy and Strength Gain: Systematic Revie… (Medicine and science in sports and exercise 2021) · cited 338x in the literature
"Although no differences in muscle hypertrophy between RT loads were found in overall (P = 0.113-0.469) or subgroup analysis (P = 0.871-0.995), greater effects were observed in untrained participants (P = 0.033) and participants with some training background who undertook more RT sessions (P = 0.031-0.045)." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Muscle hypertrophy and strength gains after resistance training with different volume-matc… (Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme 2022) · cited 116x in the literature
"A pooled analysis of the standardized mean difference for hypertrophy outcomes across all studies showed no differences between training loads. Our findings indicate that when the volume load is equal between conditions, the highest loads induce superior dynamic strength gains. Alternatively, hypertrophic adaptations were similar irrespective of the load magnitude." (abstract, results, passage verified)
pubmedfull study (doi)
Studies demonstrate that resistance training decreases lower back pain.
"But in studies looking at lower back pain and lifting, they show it decreases lower back pain, because, one, you decrease your sensitivity to pain because you're progressively loading those tissues." (said at 0:58:28)
Multiple systematic reviews and meta-analyses of randomized controlled trials demonstrate that progressive resistance training significantly reduces pain intensity and improves functional disability in individuals with chronic nonspecific low back pain. A 2026 meta-analysis of 10 randomized trials found that resistance training led to statistically and clinically significant reductions in pain intensity (SMD = -1.15) compared to control or alternative interventions, with moderate certainty of evidence.
- supports: Posterior-Chain Resistance Training Compared to General Exercise and Walking Programmes fo… (Sports medicine - open 2021) · cited 45x in the literature
"Specifically, when compared to GE, PCRT demonstrated a greater reduction in pain (SMD = - 0.61 (95% CI - 1.21 to 0.00), p = 0.05; I 2 = 74%) and level of disability (SMD = - 0.53 (95% CI - 0.97 to - 0.09), p = 0.02; I 2 = 52%), as well as a greater increase in muscle strength" (abstract, results, passage verified)
pubmedfull study (doi) - supports: Does resistance training improve pain intensity, quality of life, and disability in people… (Disability and rehabilitation 2026) · cited 2x in the literature
"Ten RCTs ( n = 434) showed significant improvements in pain intensity (SMD = -1.15; 95% CI [-1.67, -0.62], p < 0.0001), quality of life (SMD = 0.82; 95% CI [0.19, 1.46], p = 0.01), and disability (SMD = -2.76; 95% CI [-3.90, -1.62], p < 0.00001) favoring RT. Only pain intensity reached clinical significance. The certainty of the evidence was rated as "moderate" for all variables. RT programs effectively reduce pain intensity and disability in patients with NSCLBP." (abstract, results, passage verified)
pubmedfull study (doi)
Drastic increases in training volume or load without proper preparation are major risk factors for acute injury.
"If you are drastically increasing your volume or your load, that is one of the big risk factors for acute injury, okay?" (said at 1:01:05)
Rapid or drastic spikes in training load and volume relative to an athlete's chronic preparation (often measured via the acute:chronic workload ratio) are well-documented risk factors for sports-related injuries. Systematic reviews and consensus guidelines, including the International Olympic Committee consensus statement on training load and injury risk, consistently identify sudden load increases and poor load management as key contributors to injury.
Patients who possess a mindset of strength and resilience recover more rapidly from injuries and experience less pain compared to those who view themselves as fragile.
"And actually, people who get injuries, mindset is actually a big factor for recovery. People who believe that they are strong and resilient recover faster from injuries and have less pain than people who believe that they're fragile." (said at 1:04:30)
Evidence from systematic reviews and observational cohorts supports the claim that psychological resilience and positive adaptive mindsets are associated with faster recovery trajectories, fewer reported symptoms, and improved functional and pain-related outcomes after injuries or orthopaedic procedures. Systematic syntheses of injured athlete cohorts and surgical populations demonstrate that individuals with higher resilience exhibit quicker recovery curves, lower symptom burdens, and more adaptive rehabilitation engagement compared to individuals with lower resilience or higher psychological vulnerability.
- supports: The Impact of Resilience on Injury Incidence, Recovery, and Performance in Athletes: A Sys… (Orthopaedic journal of sports medicine 2025) · cited 8x in the literature
"A qualitative synthesis of the findings highlights resilience's significant positive impact on recovery and performance. Across the studies, high resilience was associated with better psychological well-being during recovery, reduced severity and incidence of post-concussion symptoms, and improved athletic performance." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Psychological resilience and sports injury among athletes: a systematic review of injury i… (BMC psychology 2026)
"Resilience had the strongest and most consistent effects on the recovery phase as noted after an injury has been sustained. In this case, a more resilient person exhibited quicker recovery curves, less load of symptoms, including post-concussion syndrome, lesser concentrations of injury stress, and enhanced adaptive attitudes towards rehabilitation." (abstract, results, passage verified)
pubmedfull study (doi) - supports: The Association of Preoperative Patient Resilience With Postoperative Patient-Reported Out… (Cureus 2026)
"Higher preoperative resilience was significantly associated with better outcomes across multiple measures, including the Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Health (PH) and Mental Health (MH) (both p < 0.001), the Knee Injury and Osteoarthritis Outcome Score (KOOS) (p < 0.05), the EuroQol Group 5 Dimension (EQ-5D) (p < 0.001), the EuroQol Group Visual Analogue Scale (EQ-VAS) (p < 0.001), and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) (p < 0.05)." (abstract, results, passage verified)
pubmedfull study (doi)
Fibromyalgia, chronic fatigue syndrome, autoimmune disorders, and IBS are tightly associated with psychological stress and psychiatric disorders.
"So if you look at fibromyalgia, chronic fatigue syndrome, in fact, a lot of autoimmune disorders are very tightly associated with psychological stress and psychiatric disorders, IBS as well." (said at 1:05:15)
Extensive epidemiological and cohort research demonstrates strong associations between psychological stress/psychiatric conditions and functional somatic syndromes (fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome) as well as autoimmune disorders. Large population-based studies, such as the Lifelines cohort (n = 122,366 adults), show high rates of comorbid DSM-IV psychiatric disorders and strong correlations with stressful life events across fibromyalgia, chronic fatigue syndrome, and IBS. Furthermore, a nationwide Swedish cohort study of 106,464 individuals demonstrated that stress-related disorders (such as PTSD and acute stress reactions) were significantly associated with an increased subsequent risk of developing autoimmune diseases (HR 1.36 overall, and HR 2.29 for multiple autoimmune diseases in PTSD patients).
- supports: Irritable bowel syndrome: relations with functional, mental, and somatoform disorders. (World journal of gastroenterology 2014) · cited 144x in the literature
"IBS is considered to be a functional somatic syndrome (FSS) with a considerable symptom overlap with other FSSs like chronic fatigue syndrome or fibromyalgia syndrome. IBS patients show an increased prevalence of psychiatric symptoms and disorders, especially depression and anxiety." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Association of Stress-Related Disorders With Subsequent Autoimmune Disease. (JAMA 2018) · cited 442x in the literature
"Compared with the unexposed population, patients with stress-related disorders were at increased risk of autoimmune disease (HR, 1.36 [95% CI, 1.33-1.40]). The HRs for patients with posttraumatic stress disorder were 1.46 (95% CI, 1.32-1.61) for any and 2.29 (95% CI, 1.72-3.04) for multiple (≥3) autoimmune diseases." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Psychiatric disorders comorbid with general medical illnesses and functional somatic disor… (PloS one 2023) · cited 18x in the literature
"The Lifelines cohort study included 122,366 adults with relevant data for 6 self-reported conditions: irritable bowel syndrome (IBS), fibromyalgia, chronic fatigue syndrome (CFS), inflammatory bowel disease (IBD), rheumatoid arthritis (RA), and diabetes... The prevalence of psychiatric disorder was higher (17-27%) in the functional somatic syndromes than the general medical illnesses (10.4-11.7%). The variables closely associated with psychiatric disorder were similar in the functional syndromes and general medical illnesses: stressful life events, chronic personal health difficulties, neuroticism, poor perception of general health..." (abstract, methods and results, passage verified)
pubmedfull study (doi)
There is little scientific evidence supporting the need to alter resistance training for different phases of the menstrual cycle.
"There's really not a lot of evidence that you need to train differently for any phase of your cycle, but if you personally feel worse during a certain phase of your cycle or even a certain day, who who cares if it's the cycle, if it's the sleep, if it's the hormones—who cares what it is?" (said at 1:19:10)
The scientific evidence supporting phase-based alteration or periodization of resistance training across the menstrual cycle is currently sparse, methodologically limited, and inconclusive. Systematic reviews of the literature show that while acute physiological performance and muscle damage markers may vary slightly across cycle phases, there is insufficient evidence to recommend specific phase-based resistance training programs over standard progressive overload.
Basal metabolic rate and total energy expenditure on average do not change significantly due to menopause itself.
"if you look at the mechanistic stuff of like BMR, total energy expenditure, you know, all the like hard metrics, they don't really change with menopause. So your BMR doesn't change. So I said total energy expenditure on average" (said at 1:20:42)
Large-scale metabolic data using the gold-standard doubly labeled water method demonstrate that total daily energy expenditure and basal/resting metabolic rate remain stable throughout adulthood between ages 20 and 60, showing no distinct decline or inflection point during midlife or the menopause transition (PMID: 34385400). While earlier, smaller studies suggested potential decreases in resting metabolic rate or physical activity during menopause (PMID: 9894924), comprehensive life-course analysis confirms that adjusted energy expenditure is maintained across adulthood and does not drop significantly as a direct result of menopause.
Basal metabolic rate accounts for approximately 50% to 70% of total daily energy expenditure in most individuals.
"Well, metabolism is your BMR, that's basically the cost of keeping the lights on, right, like that's the cost to run your organs when you're at rest. That is usually a pretty big chunk of your total energy expenditure, that's like 50 to 70% per day for most people." (said at 1:20:42)
Basal metabolic rate (BMR) represents the baseline energy required to maintain cellular homeostasis and vital organ function at complete rest in a post-absorptive state. Published nutritional and physiological literature confirms that BMR (or resting energy expenditure) constitutes the largest component of total daily energy expenditure (TDEE), typically accounting for roughly 60% to 70% of TDEE in sedentary to moderately active adults and approximately 50% in highly active individuals.
Losing 10% of body weight causes an average 15% decline in basal metabolic rate beyond what is expected from lost mass.
"so we know if you diet, lose like 10% of your body weight, it can decrease your BMR. We call that metabolic adaptation outside of what you would expect just based on the amount of mass you lose. So it's about on average like 15% decline in BMR." (said at 1:22:00)
Classic metabolic chamber and inpatient feeding studies demonstrate that maintaining a 10% reduction in body weight produces a compensatory decline in energy expenditure beyond what is predicted by changes in body mass and composition (adaptive thermogenesis / metabolic adaptation). While the largest component of this adaptation occurs in non-resting energy expenditure, resting energy expenditure (REE/BMR) also decreases by approximately 3 to 4 kcal per kilogram of fat-free mass per day (amounting to roughly a 10% to 15% disproportionate decline in adjusted resting expenditure).
Replacing low estrogen can increase energy expenditure by approximately 100 calories per day.
"there is some evidence that like if you get—if you get like really low in estrogen and you replace that, that can have an effect on energy expenditure, about 100 calories per day, something like that." (said at 1:24:05)
Experimental studies in humans support the claim that suppressing ovarian hormones reduces energy expenditure and that estradiol replacement prevents this reduction by roughly 50 to 100 kcal/day. In a randomized controlled trial of premenopausal women undergoing pharmacologic sex hormone suppression with a GnRH agonist, resting energy expenditure decreased by an average of 54 kcal/day in the placebo group but was maintained (+6 kcal/day) in those receiving estradiol add-back therapy. Total daily energy expenditure decreased by 128 kcal/day under hormone suppression with placebo.
- supports: Sex hormone suppression reduces resting energy expenditure and {beta}-adrenergic support o… (The Journal of clinical endocrinology and metabolism 2005) · cited 101x in the literature
"Treatment with GnRHant significantly decreased REE (1405 +/- 42 vs. 1334 +/- 36 kcal/d, mean +/- se, ML vs. GnRHant; P = 0.002)." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Regulation of energy expenditure by estradiol in premenopausal women. (Journal of applied physiology (Bethesda, Md. : 1985) 2015) · cited 57x in the literature
"REE decreased in GnRHAG+PL [mean (95% CI), -54 (-98, -15) kcal/d], but not GnRHAG+E2 [+6 (-33, +45) kcal/d] (difference in between-group changes, P < 0.05). TEE decreased in GnRHAG+PL [-128 (-214, -41) kcal/d] and GnRHAG+E2 [-96 (-159, -32) kcal/d], with no significant difference in between-group changes (P = 0.55)." (abstract, results, passage verified)
pubmedfull study (doi)
Hypothyroidism can reduce basal metabolic rate by up to 25%.
"there are hormones that do make a difference for energy expenditure like thyroid hormone, right? If you're hypothyroid, it will reduce your BMR. But I think the biggest decline I've seen, like the biggest absolute max I've seen in literature, is like 25%" (said at 1:24:20)
Thyroid hormones are well-established primary regulators of resting energy expenditure and basal metabolic rate (BMR) via cellular respiration, mitochondrial uncoupling, and obligatory thermogenesis. Deficiency in thyroid hormone (hypothyroidism) decreases BMR and overall energy expenditure. In clinical and physiological literature, the reduction in basal metabolic rate associated with overt hypothyroidism typically spans from 15% to 30%, aligning closely with the stated maximum decline of roughly 25%.
Relative to starting lean mass, men and women build the same percentage of muscle mass from resistance training.
"And I mean, the research shows relative to your starting lean mass, regardless of your age or sex, you can build the same amount of muscle. So what that means, people, just to put it practically: so there's studies showing that women build the same amount as men as a percentage of the starting lean mass." (said at 1:27:48)
Systematic reviews and meta-analyses comparing muscle hypertrophy between men and women undergoing identical resistance training programs demonstrate that while men often experience slightly greater absolute gains in muscle mass (due to higher baseline muscle size), relative increases in muscle size (as a percentage of baseline or starting lean mass) are similar between sexes.
Relative to starting one-rep max, women gain a similar or slightly higher percentage of strength compared to men from resistance training.
"And we actually see that even with like strength too, that women kind of as a starting percentage of their one-rep max gain similar strength as men. In fact, it might be a little bit better, to be honest." (said at 1:28:33)
Systematic reviews and meta-analyses examining sex differences in resistance training adaptations demonstrate that relative strength gains (percentage increase relative to baseline 1RM or baseline strength) are either similar between sexes or slightly greater in women. A 2020 meta-analysis by Roberts et al. in young and middle-aged adults found similar relative lower-body strength gains between sexes, but a significant moderate effect favoring females for relative upper-body strength gains (ES = -0.60, p = 0.002). Similarly, a 2021 meta-analysis in older adults found that females experienced significantly greater relative lower-body strength gains than males (g = -0.21, p = 0.0003) with comparable relative upper-body strength gains, despite males gaining more in absolute terms.
- supports: Sex Differences in Resistance Training: A Systematic Review and Meta-Analysis. (Journal of strength and conditioning research 2020) · cited 236x in the literature
"The analysis of upper-body strength comprised 19 outcomes from 17 studies with a significant effect favoring females (ES = -0.60 ± 0.16; P = 0.002; I = 72.1). The analysis of lower-body strength comprised 23 outcomes from 23 studies with no significant difference between sexes (ES = -0.21 ± 0.16; P = 0.20; I = 74.7). We found that males and females adapted to resistance training with similar effect sizes for hypertrophy and lower-body strength, but females had a larger effect for relative upper-body strength." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Sex Differences in Adaptations in Muscle Strength and Size Following Resistance Training i… (Sports medicine (Auckland, N.Z.) 2021) · cited 95x in the literature
"Females gained more relative lower-body strength than males (g = -0.21 [95% CI -0.33, -0.10], p = 0.0003) but there were no differences in relative change for upper-body strength (g = -0.29 [95% CI -0.62, 0.04], p = 0.08) or relative muscle size (g = 0.10 [95% CI -0.04, 0.23], p = 0.16). Males gained more absolute upper-body strength (g = 0.48 [95% CI 0.09, 0.88], p = 0.016), absolute lower-body strength (g = 0.33 [95% CI 0.19, 0.47], p < 0.0001), and absolute muscle size (g = 0.45 [95% CI 0.23, 0.66], p < 0.0001)." (abstract, results)
pubmedfull study (doi)
Aging reduces the sensitivity of the mTOR translation initiation signaling pathway and decreases the abundance of cellular machinery associated with muscle protein synthesis.
"As you get older, above—I want to say the study, I think it was out of Rennie or Wolfe's lab, I can't remember which one, this was like back in 2004, but they showed not only do you get a decreased sensitivity of that pathway, you actually get like less—I think less protein, less of the actual like mTOR and the machinery associated with protein synthesis." (said at 1:36:13)
A landmark clinical physiology study by Cuthbertson et al. from Michael Rennie's research group (FASEB J, 2005) investigated muscle protein synthesis (MPS) in 44 healthy young and older men in response to essential amino acids (EAA). While basal rates of MPS were similar between groups, older adults demonstrated anabolic resistance characterized by decreased sensitivity and responsiveness of MPS to EAA, accompanied by reduced total expression (protein abundance) and impaired phosphorylation (activation) of key signaling components in the mTOR/translation initiation pathway (including mTOR, p70S6K, eIF4E-BP1, and eIF2B).
Consuming proportionately higher amounts of protein can restore a normal muscle protein synthesis response in older adults.
"So their research basically showed you could restore a normal response of muscle protein synthesis, but you have to consume proportionately more protein." (said at 1:37:10)
Human metabolic tracer trials demonstrate that aging is characterized by 'anabolic resistance,' in which older skeletal muscle exhibits a blunted muscle protein synthesis (MPS) response to standard, lower doses of dietary protein or essential amino acids compared to younger muscle. However, consuming higher per-meal doses of protein (e.g., ~35–40 g of high-quality protein vs. ~20 g in younger adults) or amino acid mixtures enriched with a higher proportion of leucine overcomes this resistance and stimulates rates of muscle protein synthesis comparable to those observed in younger adults.
In younger individuals, 10 grams of protein can stimulate muscle protein synthesis, whereas older adults require closer to 20 to 40 grams per meal.
"For younger people, 10 grams of protein probably still does stimulate protein synthesis, but as you get older, you probably need closer to 20, 30, maybe even 40 grams, depending on your own lean mass and the source of protein that you're consuming." (said at 1:39:26)
Randomized metabolic tracer studies examining the dose-response relationship between dietary protein intake and muscle protein synthesis (MPS) show that young adults demonstrate sensitive stimulation of MPS at lower protein doses, with a plateau/maximal stimulation at 20 g of intact protein. In contrast, older adults exhibit anabolic resistance: 10 g of whey protein does not significantly elevate MPS above basal levels, requiring 20 g at rest and up to 40 g post-exercise to maximize the myofibrillar protein synthesis response.
Amino acids from a pre-training meal remain elevated in systemic circulation for 4 to 5 hours or longer after ingestion.
"if you're eating a meal an hour before you go train and you go train for an hour, those amino acids are still in your system for 4 to 5 hours after you originally had them, maybe even longer depending on the source." (said at 1:40:30)
Postprandial amino acid kinetics after a mixed meal or whole-food protein source demonstrate sustained digestion, absorption, and elevation of plasma amino acids over several hours. Studies tracking plasma amino acid levels following high-protein mixed meals demonstrate that peak concentrations occur 1 to 3 hours after ingestion and circulating amino acid appearance and availability remain elevated across 4 to 5 hours post-ingestion, with duration varying by protein source, co-ingested macronutrients, and age.
Most scientific literature indicates that the benefits of daily protein intake for muscle building plateau around 1.6 to 2.0 grams per kilogram of body weight.
"literature says, you know, 1.6 to 2 g per kilogram body weight. Most literature tops out around that 1.6 number." (said at 1:41:10)
A landmark systematic review and meta-analysis of 49 randomized controlled trials with 1,863 participants (Morton et al., 2018) evaluated the impact of protein supplementation during resistance training on gains in fat-free mass and muscle size. Breakpoint analysis identified that gains in fat-free mass plateaued at a total daily protein intake of approximately 1.62 g/kg/day (with a 95% confidence interval reaching ~2.2 g/kg/day), directly supporting the claim that the literature indicates a plateau around 1.6 to 2.0 g/kg of body weight.
A dose-response study by Stuart Phillips showed 20 grams of egg albumin protein maximized muscle protein synthesis statistically, with 40 grams producing an 11% higher rate that was not statistically significant.
"Stu did a study years ago of egg albumin intake like 5, 10, 20, and 40 g of egg albumin protein, and the the take-home was that the 20 g maximized the response and it was no different than 40 g statistically. Yes, but I think 40 g was still 11% higher in rate of muscle protein synthesis" (said at 1:42:30)
A randomized crossover study from Stuart Phillips' laboratory (Moore et al., 2009) evaluated the dose response of muscle protein synthesis (MPS) to 0, 5, 10, 20, and 40 g of whole egg protein following resistance exercise in healthy young men. The study showed that MPS was maximally stimulated at 20 g, with no statistically significant difference between 20 g and 40 g. In the full study results, the mean myofibrillar protein synthesis rate after 40 g was approximately 11% higher than after 20 g (0.093%/h vs. 0.084%/h), which was not statistically significant and was accompanied by increased leucine oxidation.
Randomized controlled trials show that whey protein supplementation has either a neutral or positive (reducing) effect on inflammatory markers.
"what happens when we actually give people whey protein in randomized controlled trials? Oh, wait, it's either a neutral or positive effect on inflammation." (said at 1:45:40)
Multiple systematic reviews and meta-analyses of randomized controlled trials (RCTs) examining the impact of whey protein supplementation on systemic inflammatory markers (such as C-reactive protein, IL-6, and TNF-α) demonstrate either a neutral effect (no statistically significant change compared to control) or a modest anti-inflammatory/reducing effect in specific populations (such as individuals with elevated baseline inflammation, higher supplement doses, or older adults). Across the RCT literature, whey protein supplementation does not increase circulating inflammatory markers.
- supports: Effect of whey supplementation on circulating C-reactive protein: a meta-analysis of rando… (Nutrients 2015) · cited 42x in the literature
"The meta-analysis results of nine trials showed a slight, but no significant, reduction of 0.42 mg/L (95% CI -0.96, 0.13) in CRP level with the supplementation of whey protein and its derivates... However, they may significantly reduce CRP among participants with highly supplemental doses or increased baseline CRP levels." (abstract, results)
pubmedfull study (doi) - supports: Effects of whey and soy protein supplementation on inflammatory cytokines in older adults:… (The British journal of nutrition 2023) · cited 58x in the literature
"A significant reduction of circulating IL-6 levels following whey protein [Mean Difference (MD): -0·79, 95 % CI: -1·15, -0·42, I 2 = 96 %] and TNF-α levels following soy protein supplementation (MD: -0·16, 95 % CI: -0·26, -0·05, I 2 = 68 %) was observed." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Whey Protein Intervention and Inflammatory Factors and Oxidative Stress: Systematic Review… (Nutrition reviews 2025) · cited 6x in the literature
"The results of the present study demonstrated that WP supplementation had no significant effect on the modulation of inflammation and oxidative stress compared with the control." (abstract, results, passage verified)
pubmedfull study (doi)
Randomized feeding trials show that increasing consumption of cruciferous vegetables does not impair thyroid function or metabolic rate.
"what happens in studies where we just have people eat more cruciferous vegetables? Uh it doesn't impact their their thyroid function at all, doesn't impact their metabolic rate, and if anything they lose more weight from satiety." (said at 1:46:30)
Randomized and clinical intervention studies evaluating the ingestion of cruciferous vegetables or extracts rich in their bioactive compounds (such as sulforaphane and glucoraphanin) show that typical dietary consumption does not significantly alter thyroid function markers (such as TSH, free thyroxine, and thyroglobulin) or induce thyroid autoimmunity in humans. While cruciferous vegetables contain goitrogenic precursors (glucosinolates/progoitrins) that theoretically inhibit iodine uptake at extreme or deficient doses, human trials evaluating standard dietary increases demonstrate safety regarding thyroid hormonal status.
A meta-regression by Eric Helms showed that protein intakes up to approximately 3.1 grams per kilogram of lean mass improved lean mass retention during a caloric deficit.
"Eric Helms a few years—I don't know if you're familiar with him, but he's a researcher in exercise science, nutrition in New Zealand, and uh um he did a systematic review, and I think it was a meta-regression as well, showing that in a calorie deficit, possibly up to 3 g per kilogram of lean mass—so different than body weight, right, but still higher than what we typically see—that up to I think 3.1 g per kilogram of lean mass had uh improvements in lean mass retention during a calorie deficit." (said at 1:47:59)
The claim accurately reflects a 2014 systematic review led by Eric Helms examining dietary protein requirements during caloric restriction in resistance-trained athletes. Evaluating six studies (13 study groups), the review observed that higher protein intakes attenuated fat-free mass (FFM) loss in lean athletes undergoing energy restriction, concluding that optimal protein requirements range from 2.3 to 3.1 g/kg of FFM, scaled upwards based on athlete leanness and deficit severity.
The average American gets less than 20 minutes of physical activity per day.
"and the average person gets less than 20 minutes of physical activity per day." (said at 1:52:50)
Nationally representative surveillance data show that the average American gets under 20 minutes of daily physical activity when looking at leisure-time physical activity or objectively measured moderate-to-vigorous physical activity (MVPA). An analysis of the American Time Use Survey (ATUS, 2014–2016, n=32,048) found that American men averaged 24 minutes and women averaged 14 minutes per day of leisure-time physical activity (averaging approximately 19 minutes overall). Objective accelerometer data from NHANES have similarly shown very low levels of daily MVPA, with fewer than 5% of adults achieving 30 minutes per day of moderate-to-vigorous activity. Total movement (including light-intensity routine daily activities) is higher, but structured exercise and moderate-to-vigorous physical activity average under 20 minutes daily.
- supports: Physical activity in the United States measured by accelerometer. (Medicine and science in sports and exercise 2008) · cited 7798x in the literature
"Among adults, adherence to the recommendation to obtain 30 min x d(-1) of physical activity is less than 5%." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Free Time and Physical Activity Among Americans 15 Years or Older: Cross-Sectional Analysi… (Preventing chronic disease 2019) · cited 49x in the literature
"Men had more free time (mean [standard deviation], 356 [3] min/d) and spent more on leisure time physical activity (mean [SD], 24 [3] min/d) than women did (free time mean [SD], 318 [2] min/d, P < .001; and leisure time physical activity mean [SD], 14 [1] min/d, P < .001)." (abstract, results, passage verified)
pubmedfull study (doi)
In endurance athletes, higher protein intake improves exercise recovery up to approximately 1.6 to 1.8 grams per kilogram of body weight.
"you see better recovery from exercise with more protein in endurance athletes up to about that 1.6 g per kilogram. I think I saw one study was like up to 1.8 saw benefit as well." (said at 1:54:07)
Contemporary metabolic studies using indicator amino acid oxidation (IAAO) in endurance athletes demonstrate that protein requirements to optimize post-exercise recovery and whole-body protein synthesis plateau around an estimated average requirement of ~1.6 g/kg/day, with recommended upper intakes (covering 97.5% of the population) reaching ~1.8 to 1.85 g/kg/day.
- supports: Protein Requirements Are Increased in Endurance-Trained Athletes but Similar between Femal… (Medicine and science in sports and exercise 2023) · cited 9x in the literature
"Using a modified three-point curve resulted in a breakpoint that was not different (P = 0.94) between males and females (1.60 and 1.61 g·kg-1·d-1, respectively). The recommended intake (i.e., upper 95% confidence interval) was estimated to be 1.81 and 1.89 g·kg-1·d-1 for males and females, respectively. Our findings indicate that endurance athletes consuming a daily protein intake toward the upper end of current consensus recommendations (~1.85 g·kg-1·d-1) will maximize whole-body protein synthesis during postexercise recovery regardless of sex." (abstract, results and conclusions, passage verified)
pubmedfull study (doi) - supports: Protein Nutrition for Endurance Athletes: A Metabolic Focus on Promoting Recovery and Trai… (Sports medicine (Auckland, N.Z.) 2025) · cited 23x in the literature
"Based on findings from a series of contemporary protein requirement studies, the evidence suggests a daily protein intake of ~ 1.8 g·kgBM -1 ·day -1 should be advocated for endurance athletes, with the caveat that the protein requirement may be further elevated in excess of 2.0 g·kgBM -1 ·day -1 during periods of carbohydrate-restricted training and on rest days." (abstract, results, passage verified)
pubmedfull study (doi)
In a randomized controlled trial equating calories, overfeeding saturated fat increased liver fat 70% more than overfeeding fructose.
"they compared them straight up equating calories overfeeding fructose versus saturated fat: saturated fat increased liver fat 70% more than fructose in a randomized controlled trial." (said at 1:55:35)
The claim accurately reflects the findings of a randomized trial by Luukkonen et al. (2018; PMID 29844096). In this study, 38 overweight adults were randomized to receive 1,000 kcal/day of excess energy from saturated fat, unsaturated fat, or simple sugars (sucrose/fructose) for 3 weeks. Intrahepatic triglyceride (IHTG) content increased by 55% in the saturated fat group compared to 33% in the simple sugar group, representing approximately a 67% (rounded to ~70%) greater relative increase in liver fat from saturated fat overfeeding.
Meta-analyses of randomized trials show that when total energy is equated, sugar intake does not adversely affect inflammatory markers or blood glucose metabolism compared to other carbohydrate sources.
"if you're equating energy, like I mean I have several meta-analyses to show that it doesn't affect inflammatory markers, doesn't affect uh blood glucose metabolism, as long as you're getting in the same total calories per day compared to other diets and substituting out different carbohydrate sources." (said at 1:59:43)
Meta-analyses of randomized controlled feeding trials indicate that when energy intake is equated (isocaloric exchange), dietary sugars such as fructose do not adversely affect glycemic control or insulin levels compared to other carbohydrate sources. In a systematic review and meta-analysis of controlled feeding trials in diabetic individuals, isocaloric substitution of fructose for other carbohydrates significantly improved glycated blood proteins (HbA1c equivalent reduction of ~0.53%) without negatively altering fasting blood glucose or insulin concentrations.
Mendelian randomization studies demonstrate a direct linear relationship between lifetime exposure to LDL cholesterol and the risk of heart disease.
"And so these Mendelian randomization studies, I mean when they came out, you look at the lifetime exposure, you can draw a straight line through it. I mean you can literally draw a straight line through amount of LDL exposure throughout the course of someone's life and the risk for heart disease." (said at 2:07:24)
Large-scale Mendelian randomization meta-analyses and consensus evaluations demonstrate a consistent, dose-dependent log-linear relationship between cumulative lifetime exposure to LDL cholesterol and the risk of coronary heart disease/atherosclerotic cardiovascular disease. Long-term genetic exposure to lower LDL-C across multiple gene variants shows a uniform, proportional reduction in cardiovascular risk per unit decrease.
Stearic acid does not appear to raise LDL cholesterol levels.
"there are some forms of saturated fat that don't raise LDL, like stearic acid doesn't appear to raise LDL." (said at 2:07:55)
Multiple systematic reviews and meta-analyses of controlled dietary intervention trials show that stearic acid (18:0) behaves differently from other major saturated fatty acids (such as lauric, myristic, and palmitic acids). Unlike those saturated fats, dietary stearic acid exerts a neutral effect on low-density lipoprotein (LDL) cholesterol levels, neither raising LDL relative to carbohydrates or unsaturated fatty acids nor lowering it when replaced by unsaturated fats.
- supports: Effects of stearic acid on plasma lipid and lipoproteins in humans. (Lipids 2005) · cited 156x in the literature
"Compared with other saturated FA, stearic acid lowers LDL cholesterol." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Impact of Replacement of Individual Dietary SFAs on Circulating Lipids and Other Biomarker… (Advances in nutrition (Bethesda, Md.) 2022) · cited 38x in the literature
"Similarly, we found no evidence of a benefit from replacing dietary stearic acid (18:0) with UFAs on CMD risk markers (n = 4 RCTs)." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Plasma cholesterol-predictive equations demonstrate that stearic acid is neutral and monou… (The American journal of clinical nutrition 1995) · cited 71x in the literature
"Our analyses revealed that unlike the other long-chain saturated fatty acids (SFAs), stearic acid had no effect on TC and lipoprotein cholesterol concentrations in men and women." (abstract, results, passage verified)
pubmedfull study (doi)
Eating more saturated fat overall raises LDL cholesterol.
"But overall, if you eat more saturated fat, you raise your LDL." (said at 2:08:01)
Randomized controlled trials and systematic reviews consistently demonstrate that higher dietary intake of saturated fatty acids (SFAs) increases circulating LDL cholesterol (and conversely, reducing saturated fat or replacing it with unsaturated fatty acids reduces LDL cholesterol). A Cochrane systematic review of 15 randomized controlled trials (~59,000 participants) confirmed that dietary reduction of saturated fat leads to reductions in total cholesterol and LDL cholesterol, with greater reductions in saturated fat producing larger decreases in circulating cholesterol.
- supports: Reduction in saturated fat intake for cardiovascular disease. (The Cochrane database of systematic reviews 2020) · cited 230x in the literature
"Reducing saturated fat reduces serum cholesterol, but effects on other intermediate outcomes may be less clear." (abstract, background, passage verified)
pubmedfull study (doi) - supports: Impact of Replacement of Individual Dietary SFAs on Circulating Lipids and Other Biomarker… (Advances in nutrition (Bethesda, Md.) 2022) · cited 38x in the literature
"We observed reductions in LDL-cholesterol concentrations after the replacement of palmitic acid (16:0) with UFAs (-0.36 mmol/L; 95% CI: -0.50, -0.21 mmol/L; I2 = 96.0%, n = 18 RCTs) or oleic acid (18:1n-9) (-0.16 mmol/L; 95% CI: -0.28, -0.03 mmol/L; I2 = 89.6%, n = 9 RCTs), with a similar impact on total cholesterol and apoB concentrations." (abstract, results, passage verified)
pubmedfull study (doi)
Fasting can cause a transient increase in LDL cholesterol due to increased lipid flux from the liver.
"We know LDL transiently, if you fast, your LDL can go up, you know, because you're getting more flux out of the liver, but like that overall, over the course of time, it goes down." (said at 2:10:37)
Evidence from human fasting studies supports the claim that fasting can induce a transient elevation in LDL cholesterol before stabilizing or declining over time. A systematic review and meta-analysis of 32 human studies investigating water-only fasting observed a significant overall increase in LDL-C (Hedges' g = 0.489) that followed a biphasic trajectory—progressively rising during acute/multi-day fasting up to approximately 10 days, followed by attenuation and stabilization. Mechanistically, fasting promotes adipose tissue lipolysis and increases free fatty acid flux to the liver, altering hepatic lipid processing and circulating lipoprotein concentrations.
Replacing saturated fat with polyunsaturated fat in the diet is neutral or beneficial for cardiovascular risk and inflammation.
"But if you're replacing saturated fat with that, the evidence suggests it's neutral or positive." (said at 2:12:07)
Randomized controlled trials and systematic reviews demonstrate that replacing dietary saturated fatty acids (SFAs) with polyunsaturated fatty acids (PUFAs) yields neutral to beneficial effects on cardiovascular disease (CVD) risk and inflammatory markers. A Cochrane systematic review of 15 randomized controlled trials found that reducing dietary saturated fat reduced combined cardiovascular events by 17% (RR 0.83, 95% CI 0.70 to 0.98), with replacement by polyunsaturated fat identified as an effective strategy. Additionally, clinical trials show that substituting SFAs with PUFAs significantly lowers LDL cholesterol and total cholesterol, while modulating gene expression pathways involved in immune response and inflammation.
- supports: Replacement of saturated with unsaturated fats had no impact on vascular function but bene… (The American journal of clinical nutrition 2015) · cited 179x in the literature
"Replacement with MUFAs or n-6 PUFAs lowered fasting serum total cholesterol (-8.4% and -9.2%, respectively), low-density lipoprotein cholesterol (-11.3% and -13.6%), and total cholesterol to high-density lipoprotein cholesterol ratio (-5.6% and -8.5%) (P ≤ 0.001). These changes in low-density lipoprotein cholesterol equate to an estimated 17-20% reduction in CVD mortality." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Reduction in saturated fat intake for cardiovascular disease. (The Cochrane database of systematic reviews 2020)
"The included long-term trials suggested that reducing dietary saturated fat reduced the risk of combined cardiovascular events by 17% (risk ratio (RR) 0.83; 95% confidence interval (CI) 0.70 to 0.98, 12 trials, 53,758 participants of whom 8% had a cardiovascular event, I² = 67%, GRADE moderate-quality evidence). [...] Replacing the energy from saturated fat with polyunsaturated fat or carbohydrate appear to be useful strategies" (abstract, results and conclusions, passage verified)
pubmedfull study (doi) - supports: Saturated Fat Intake and the Prevention and Management of Cardiovascular Disease in Adults… (Journal of the Academy of Nutrition and Dietetics 2023) · cited 12x in the literature
"Moderate evidence supports the reduction of SFA intake for CVD event reduction, low- to moderate-certainty evidence supports prioritization of replacement of SFAs with polyunsaturated fatty acids" (abstract, objective, passage verified)
pubmedfull study (doi)
A large cohort meta-analysis found that replacing saturated fats with polyunsaturated fats reduced cardiovascular disease risk more strongly in a dose-response manner than replacing them with monounsaturated fats.
"there was one really big cohort meta-analysis that was done that kind of showed that monounsaturated didn't have as big of an effect as polyunsaturated as decreasing the risk of cardiovascular disease, that monounsaturated was still positive and saturated was negative, but polyunsaturated was kind of better in a dose response." (said at 2:15:25)
A landmark pooled analysis of 11 prospective cohort studies encompassing 344,696 participants (Jakobsen et al., 2009) examined the substitution of dietary saturated fatty acids (SFAs) with other macronutrients. The analysis demonstrated that isocalorically replacing 5% of energy intake from SFAs with polyunsaturated fatty acids (PUFAs) significantly reduced the risk of coronary events by 13% (HR 0.87, 95% CI: 0.77–0.97) and coronary deaths by 26% (HR 0.74, 95% CI: 0.61–0.89) across a linear dose-response range. In contrast, substitution of SFAs with monounsaturated fatty acids (MUFAs) showed no significant reduction in coronary heart disease risk. Subsequent large meta-analyses of prospective cohorts have confirmed that replacing saturated fats with polyunsaturated fats provides stronger and more consistent cardiovascular risk reductions than replacement with monounsaturated fats or carbohydrates.
When caloric intake is controlled, meta-analyses of randomized trials substituting sugars or sugar-sweetened beverages isocalorically for other carbohydrates show no differences in fat mass, body weight, or inflammation.
"If they look at studies where they substitute isocalorically, they don't really see a difference on sugar-sweetened beverages or fructose-containing beverages, I think was one of the the meta-analyses I looked at" (said at 2:25:30)
Systematic reviews and meta-analyses of controlled feeding trials have consistently found that when fructose or sugars are substituted isocalorically for other carbohydrate sources, there is no significant difference in body weight or markers of liver fat accumulation. Significant adverse effects on body weight and metabolic parameters are primarily observed in hypercaloric feeding conditions where sugars provide excess energy relative to control diets.
- supports: Effect of fructose on body weight in controlled feeding trials: a systematic review and me… (Annals of internal medicine 2012) · cited 294x in the literature
"Fructose had no overall effect on body weight in isocaloric trials (mean difference, -0.14 kg [95% CI, -0.37 to 0.10 kg] for fructose compared with nonfructose carbohydrate). High doses of fructose in hypercaloric trials (+104 to 250 g/d, +18% to 97% of total daily energy intake) lead to significant increases in weight (mean difference, 0.53 kg [CI, 0.26 to 0.79 kg] with fructose)." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic r… (European journal of clinical nutrition 2014) · cited 318x in the literature
"Isocaloric exchange of fructose for other carbohydrates does not induce NAFLD changes in healthy participants. Fructose providing excess energy at extreme doses, however, does raise IHCL and ALT, an effect that may be more attributable to excess energy than fructose." (abstract, conclusions, passage verified)
pubmedfull study (doi)
Meta-analyses show that artificial and non-nutritive sweeteners do not cause an insulin response in humans.
"there's several meta-analyses now to show that that doesn't happen with any of the sweeteners that we know of." (said at 2:30:10)
Systematic reviews and meta-analyses of acute human intervention trials show that non-nutritive and artificial sweeteners (including aspartame, acesulfame potassium, cyclamate, saccharin, stevia, and sucralose, either individually or in blends) do not stimulate an acute postprandial insulin or glucose response, behaving indistinguishably from water controls. In contrast, caloric sugars elicit pronounced acute insulin and glucose elevations.
- supports: The Effect of Non-Nutritive Sweetened Beverages on Postprandial Glycemic and Endocrine Res… (Nutrients 2023) · cited 52x in the literature
"In uncoupling interventions, NNS beverages (single or blends) had no effect on postprandial glucose, insulin, GLP-1, GIP, PYY, ghrelin, and glucagon responses similar to water controls (generally, low to moderate confidence), whereas SSBs sweetened with caloric sugars (glucose and sucrose) increased postprandial glucose, insulin, GLP-1, and GIP responses with no differences in postprandial ghrelin and glucagon responses" (abstract, results, passage verified)
pubmedfull study (doi) - supports: The Effects of Aspartame on Glucose, Insulin, and Appetite-Regulating Hormone Responses in… (Advances in nutrition (Bethesda, Md.) 2025) · cited 2x in the literature
"Meta-analyses (acute cross-over studies) revealed few effects of aspartame on blood glucose/insulin compared with vehicle or low-calorie sweeteners (LCS), and lower blood glucose/insulin concentrations compared with sugars, other carbohydrates, or other nutritive elements." (abstract, results, passage verified)
pubmedfull study (doi)
Maltodextrin produces a greater glycemic response than sucrose.
"maltodextrin is not as sweet as sucrose, but it has a much greater glycemic response than sucrose does" (said at 2:31:05)
Maltodextrin is a rapidly digested glucose polymer with a glycemic index (GI) typically ranging from 85 to over 100, eliciting a postprandial blood glucose response similar to or exceeding pure glucose. In contrast, sucrose is a disaccharide composed of 50% glucose and 50% fructose; because fructose undergoes hepatic metabolism and contributes minimally to immediate systemic glycemia, sucrose has a significantly lower glycemic index (typically around 65). Human clinical crossover trials consistently demonstrate that maltodextrin yields a substantially higher postprandial glycemic response than sucrose.
A study investigating sucralose found it increased the proportion of the gut bacterium Blautia coccoides.
"for example, in one of the studies looking at sucralose, they actually saw an increase in the proportion of a bacteria—and I'll probably butcher the name—Blautia coccoides, I want to say it is, something like that." (said at 2:32:41)
In an open-label randomized clinical trial evaluating daily consumption of 48 mg sucralose for 10 weeks in healthy young adults (n = 40), sucralose intake led to a significant 3-fold increase in the abundance of Blautia coccoides compared to the control group.
Cohort studies consistently demonstrate that dietary fiber intake is associated with reduced risk of cardiovascular disease, cancer, and all-cause mortality in a dose-response manner.
"Like fiber—very confident that fiber is good for health, cardiovascular disease, cancer, mortality, because I am not aware of a single study looking at fiber intake in a cohort that did not show protective effects and in a dose-response manner." (said at 2:34:20)
A landmark systematic review and meta-analysis commissioned by the World Health Organization (Reynolds et al., 2019, Lancet) synthesizing 185 prospective cohort studies (encompassing nearly 135 million person-years) and 58 clinical trials confirmed that higher dietary fiber intake is consistently associated with a 15% to 30% reduction in all-cause mortality, cardiovascular-related mortality, coronary heart disease incidence, and incidence of colorectal and breast cancers. Dose-response analyses indicated progressive risk reductions with increasing daily fiber intake (particularly between 25 g and 29 g per day and beyond).
High LDL cholesterol at low inflammation levels confers a higher cardiovascular risk than low LDL cholesterol at low inflammation levels, and high LDL confers increased risk above low LDL at high inflammation levels.
"at low inflammation, high LDL with low inflammation still has a higher risk than low LDL at low inflammation. And at high inflammation, high LDL is still increased risk above low LDL at both those levels." (said at 2:38:19)
Large prospective cohort and randomized trial follow-up studies, including the Women's Health Study (Ridker et al., 2002 and 2024), demonstrate that LDL cholesterol and inflammatory biomarkers such as high-sensitivity C-reactive protein (hs-CRP) are minimally correlated and act as independent predictors of cardiovascular risk. Across stratified categories, high LDL cholesterol confers increased cardiovascular risk compared to low LDL cholesterol among individuals with low baseline inflammation, and it continues to add incremental risk above low LDL cholesterol among individuals with elevated inflammation.
- supports: Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the pre… (The New England journal of medicine 2002) · cited 3619x in the literature
"Although C-reactive protein and LDL cholesterol were minimally correlated (r=0.08), base-line levels of each had a strong linear relation with the incidence of cardiovascular events... By contrast, because C-reactive protein and LDL cholesterol measurements tended to identify different high-risk groups, screening for both biologic markers provided better prognostic information than screening for either alone." (abstract, results)
pubmedfull study (doi) - supports: Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women. (The New England journal of medicine 2024) · cited 269x in the literature
"Quintiles of increasing baseline levels of high-sensitivity CRP, LDL cholesterol, and lipoprotein(a) all predicted 30-year risks. Covariable-adjusted hazard ratios for the primary end point in a comparison of the top with the bottom quintile were 1.70 (95% confidence interval [CI], 1.52 to 1.90) for high-sensitivity CRP, 1.36 (95% CI, 1.23 to 1.52) for LDL cholesterol, and 1.33 (95% CI, 1.21 to 1.47) for lipoprotein(a)... Each biomarker showed independent contributions to overall risk." (abstract, results, passage verified)
pubmedfull study (doi)
Aspartame is metabolized in the human body into phenylalanine, aspartate, and methanol.
"If we take aspartame, for example, I mean, we know what it's metabolized into: it's two amino acids, and it gets metabolized into phenylalanine and aspartate, and then methanol" (said at 2:41:29)
Aspartame is a dipeptide artificial sweetener that is broken down and metabolized in the gastrointestinal tract into three primary components: the amino acids phenylalanine (approximately 50%) and aspartic acid (aspartate, approximately 40%), along with methanol (approximately 10%).
Time-restricted eating, calorie restriction, and exercise all increase cellular autophagy.
"yes, time-restricted eating raises autophagy, but so does calorie restriction, and so does exercise." (said at 2:45:48)
Scientific literature supports the claim that time-restricted eating (intermittent fasting), calorie restriction, and exercise all induce cellular autophagy. Autophagy is an evolutionary conserved cellular recycling mechanism activated in response to nutrient scarcity and energy expenditure, such as during caloric deficit, fasting windows, or physical exertion. While these pathways are heavily documented in preclinical models and human cellular signaling studies, direct real-time measurement of autophagy in human clinical settings remains methodologically challenging.
- supports: Molecular mechanisms underlying the beneficial effects of exercise and dietary interventio… (Journal of cardiovascular medicine (Hagerstown, Md.) 2023) · cited 9x in the literature
"Lifestyle changes include exercise and dietary restriction protocols, such as calorie restriction and intermittent fasting, which were shown to delay cardiovascular ageing and elicit health-promoting effects in preclinical models of cardiometabolic diseases. Beneficial effects are mediated by the restoration of multiple molecular mechanisms in heart and vessels that are compromised by metabolic stress. Exercise and dietary restriction rescue mitochondrial dysfunction, oxidative stress and inflammation. They also improve autophagy." (abstract, passage verified)
pubmedfull study (doi) - supports: Links Between Autophagy and Healthy Aging. (Journal of molecular biology 2026) · cited 4x in the literature
"Specifically, we review the molecular mechanisms through which pharmacological agents, dietary restriction, exercise, sleep adjustments, as well as temperature modulation affect autophagy to extend lifespan and often also healthspan in model organisms and humans." (abstract, passage verified)
pubmedfull study (doi) - supports: Regulation of autophagy-mediated pathways by diet, physical activity, and sleep in Alzheim… (Alzheimer's & dementia : the journal of the Alzheimer's Association 2026) · cited 2x in the literature
"Intermittent fasting (IF) and calorie restriction (CR) activate autophagy and promote longevity; physical activity enhances cerebral blood flow and neurotrophic signaling; and adequate sleep supports autophagic processes, while sleep deprivation disrupts them." (abstract, passage verified)
pubmedfull study (doi)
Unlike humans whose growth plateaus in early adulthood, rodents continue to grow throughout the course of their life.
"rodents grow throughout the course of their life. Humans kind of peak at like around 20, and then they kind of stay level, I mean, obesity notwithstanding, and then they start to decline later in life—very different growth curve from rodents." (said at 3:07:19)
Rodents such as laboratory rats and mice differ from humans in their skeletal growth dynamics. In humans, epiphyseal growth plates fuse shortly after sexual maturity (typically around late adolescence/early adulthood), leading to a cessation of longitudinal skeletal growth. In contrast, rodents do not undergo complete epiphyseal fusion at sexual maturity and continue longitudinal bone growth and mass accretion across much or all of their lifespan.
Scientific research consistently demonstrates that caffeine acts as a nootropic cognitive enhancer.
"caffeine is the original nootropic cognitive enhancer—pretty consistent data on that." (said at 3:11:24)
A substantial body of randomized controlled trials and systematic meta-analyses confirms that caffeine reliably enhances multiple cognitive domains. Meta-analyses demonstrate consistent improvements in attention, reaction time, response speed, information processing, vigilance, and error reduction across both rested and sleep-deprived conditions.
- supports: Caffeine for the prevention of injuries and errors in shift workers. (The Cochrane database of systematic reviews 2010) · cited 130x in the literature
"The pooled effect estimates on performance by cognitive domain suggest that, when compared to placebo, caffeine improved concept formation and reasoning (SMD -0.41; 95% CI -1.04 to 0.23), memory (SMD -1.08; 95% CI -2.07 to -0.09), orientation and attention (SMD -0.55; 95% CI -0.83 to -0.27) and perception (SMD -0.77; 95% CI -1.73 to 0.20)" (abstract, results, passage verified)
pubmedfull study (doi) - supports: Effects of acute caffeine consumption following sleep loss on cognitive, physical, occupat… (Neuroscience and biobehavioral reviews 2020) · cited 75x in the literature
"Caffeine improved response time (44 EEs; g = 0.86; 95 % CI: 0.53-0.83) and accuracy (27 EEs; g = 0.68; 95 % CI: 0.48-0.88) on attention tests, improved executive function (38 EEs; g = 0.35; 95 % CI: 0.15-0.55), improved reaction time (12 EEs; g = 1.11; 95 % CI: 0.75-1.47), improved response time (20 EEs; g = 1.95; 95 % CI: 1.39-2.52) and accuracy (34 EEs; g = 0.43; 95 % CI: 0.30-0.55) on information processing tasks" (abstract, results, passage verified)
pubmedfull study (doi) - supports: Caffeine and Cognitive Functions in Sports: A Systematic Review and Meta-Analysis. (Nutrients 2021) · cited 84x in the literature
"After pooling data in the meta-analysis, the significant impacts of caffeine only emerged on attention, accuracy, and speed. The results of the 13 studies, nevertheless, suggest that the intake of a low/moderate dose of caffeine before and/or during exercise can improve self-reported energy, mood, and cognitive functions, such as attention" (abstract, results, passage verified)
pubmedfull study (doi)
Clinical research shows that creatine supplementation helps with symptoms of depression.
"Depression: there was a study that showed that creatine helped a little bit with symptoms of depression." (said at 3:17:02)
Clinical studies have investigated creatine supplementation (often as an adjunctive treatment to standard antidepressant therapy) for symptoms of depression. A notable randomized, double-blind, placebo-controlled trial in women with major depressive disorder found that creatine augmentation (5 g/day) alongside escitalopram led to significantly greater reductions in depressive symptoms on the Hamilton Depression Rating Scale. A 2025 systematic review and meta-analysis of 11 randomized trials (1,093 participants) similarly found a small reduction in depressive symptoms (standardized mean difference of -0.34), although overall certainty remains low due to study heterogeneity, small sample sizes, and potential risk of bias.
Creatine supplementation can elevate serum creatinine levels without indicating kidney impairment.
"I mean, if you take creatine, you might see your creatinine levels go up. It doesn't mean your kidneys are failing or anything like that." (said at 3:17:02)
Creatine is non-enzymatically converted into creatinine as a metabolic byproduct. Increased dietary creatine intake expands the body's total creatine pool, which can lead to elevated serum creatinine concentrations and false-positive indications of impaired renal clearance on standard creatinine-based estimated glomerular filtration rate (eGFR) tests. Systematic reviews and meta-analyses of randomized clinical trials confirm that this increase in serum creatinine does not reflect actual renal impairment or true changes in glomerular filtration rate.
Multiple long randomized controlled trials show that creatine supplementation does not adversely impact kidney function.
"there's so many long randomized controlled trials looking directly at kidney function showing that creatine does not negatively impact kidney function." (said at 3:17:32)
Multiple randomized controlled trials and meta-analyses support the claim that creatine supplementation does not adversely impact actual kidney function (such as glomerular filtration rate or urea levels). While creatine intake causes a slight increase in serum creatinine due to metabolic conversion to creatinine, systematic reviews and RCTs evaluating direct measures of renal function (e.g., 51Cr-EDTA clearance, eGFR, cystatin C, blood urea nitrogen, albuminuria) show no significant negative effect across short-term, medium-term, and long-term (up to 2 years) interventions.
- supports: Long-term creatine supplementation is safe in aged patients with Parkinson disease. (Nutrition research (New York, N.Y.) 2008) · cited 82x in the literature
"Although serum creatinine levels increased in Cr patients because of the degradation of Cr, all other markers of tubular or glomerular renal function, especially cystatin C, remained normal, indicating unaltered kidney function." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Does long-term creatine supplementation impair kidney function in resistance-trained indiv… (Journal of the International Society of Sports Nutrition 2013) · cited 67x in the literature
"A 12-week creatine supplementation protocol did not affect kidney function in resistance-trained healthy individuals consuming a high-protein diet; thus reinforcing the safety of this dietary supplement." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Effect of creatine supplementation on kidney function: a systematic review and meta-analys… (BMC nephrology 2025) · cited 14x in the literature
"Creatine supplementation is associated with a modest, transient increase in serum creatinine levels, likely due to metabolic turnover rather than renal impairment. No significant changes were observed in GFR, suggesting preserved kidney function." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: The effect of creatine supplementation on kidney function: a systematic review and meta-an… (Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 2026) · cited 1x in the literature
"Cre supplementation seems to relate to an increase in serum Crn, but this is not related to significant alterations in urea concentrations and eGFR." (abstract, conclusions, passage verified)
pubmedfull study (doi)
The 2009 study linking creatine to DHT increases did not measure hair loss and did not show changes in the precursor or subsequent metabolites of DHT.
"One study in 2009 showed it increased DHT, okay, which is a metabolite of testosterone. It didn't show any changes in the precursor or the thing that comes after DHT. ... And more importantly, hair loss wasn't measured." (said at 3:17:32)
The 2009 study by van der Merwe et al. (PMID 19741313) evaluated serum testosterone (T) and dihydrotestosterone (DHT) in 20 male rugby players over 3 weeks of creatine monohydrate supplementation. The study found that while DHT concentrations increased by 56% after 7 days of loading and remained 40% above baseline after 14 days of maintenance, serum levels of its precursor, testosterone, did not change. Furthermore, the trial evaluated endocrine and body composition markers only and did not assess or measure hair loss.
Randomized controlled trials indicate that while whey protein causes an acute insulin response, long-term insulin sensitivity does not worsen and may improve.
"let's look at the randomized controlled trials. Okay, yeah, it does seem to have an insulin response. It does. But does insulin sensitivity get worse? No, if anything, in the studies, it gets better." (said at 3:19:47)
Randomized controlled trials and meta-analyses confirm that while whey protein stimulates an acute postprandial insulin secretion (incretin-mediated), chronic whey protein supplementation does not impair long-term insulin sensitivity. Instead, systematic reviews and meta-analyses of RCTs show that whey protein either maintains or modestly improves markers of insulin resistance (such as lowering HOMA-IR and fasting insulin), particularly in individuals with metabolic syndrome or overweight/obesity.
- supports: Effects of whey protein on glycemic control and serum lipoproteins in patients with metabo… (Lipids in health and disease 2020) · cited 46x in the literature
"Consumption of whey protein resulted in significant reduction of HbA1c (WMD: -0.15; 95% CI: - 0.29, - 0.01) insulin (WMD: -0.94; 95% CI: - 1.68, - 0.21) and homeostasis model assessment-estimated insulin resistance (HOMA-IR) (WMD: -0.20; 95% CI: - 0.36, - 0.05)." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Effects of supplementation with milk protein on glycemic parameters: a GRADE-assessed syst… (Nutrition journal 2023) · cited 12x in the literature
"It was displayed that supplementation with MP effectively reduced levels of fasting blood glucose (FBG) (weighted mean difference (WMD): -1.83 mg/dL, 95% CI: -3.28, -0.38; P = 0.013), fasting insulin (WMD: -1.06 uU/mL, 95% CI: -1.76, -0.36; P = 0.003), and homeostasis model assessment of insulin resistance (HOMA-IR) (WMD: -0.27, 95% CI: -0.40, -0.14; P < 0.001)" (abstract, results, passage verified)
pubmedfull study (doi)
Fat consumption acutely impairs flow-mediated dilation after a meal.
"fat impedes flow-mediated dilation after a meal" (said at 3:20:02)
A 2022 systematic review and meta-analysis of 90 studies evaluated the acute effects of a high-fat meal on flow-mediated dilation (FMD), a standard measure of nitric oxide–dependent endothelial function. The meta-analysis confirmed that consuming a high-fat meal transiently impairs endothelial function, significantly decreasing postprandial FMD at 2, 3, and 4 hours post-ingestion across diverse participant groups.
Rhodiola rosea improves time to fatigue and perception of fatigue during exercise.
"Rhodiola rosea as a as a cognitive enhancer, as an adaptogen. It improves time to fatigue and improves perception of fatigue, and appears to be pretty consistent." (said at 3:20:32)
A systematic review and meta-analysis of randomized controlled trials examining Rhodiola rosea supplementation found significant improvements in endurance performance measures, including time to exhaustion (TTE) and time trial performance, alongside beneficial shifts in metabolic and oxidative markers. In addition, randomized clinical trials demonstrate that Rhodiola rosea supplementation reduces ratings of perceived exertion and subjective fatigue during athletic and exercise tests.
- supports: The effect of Rhodiola rosea supplementation on endurance performance and related biomarke… (Frontiers in nutrition 2025) · cited 3x in the literature
"The results indicated that RR supplementation significantly improved endurance-related outcomes, including VO 2max (11 studies; ES = 0.32, p < 0.01), time to exhaustion (TTE; 7 studies; ES = 0.38, p < 0.05), and time trial performance (TTP; 5 studies; ES = -0.40, p < 0.05)." (abstract, results, passage verified)
pubmedfull study (doi) - supports: The Effect of Short-Term Rhodiola rosea Supplementation on Simulated Game Time, Perceived … (Nutrients 2025) · cited 3x in the literature
"Conclusions : Short-term Rhodiola rosea supplementation can improve sprint performance and reduce perceived fatigue in basketball players during simulated games, enhance aerobic work capacity, and delay fatigue." (abstract, conclusions, passage verified)
pubmedfull study (doi)
Meta-analyses demonstrate that ashwagandha supplementation improves lean mass, strength, sleep, and stress management.
"There's a few meta-analyses now showing improved lean mass, improved strength, improved sleep, better stress management." (said at 3:22:02)
Multiple systematic reviews and meta-analyses of randomized controlled trials support the claim that Withania somnifera (ashwagandha) supplementation yields improvements across these domains. Meta-analyses demonstrate statistically significant reductions in perceived stress and cortisol levels (e.g., Akhgarjand et al., 2022; Gopukumar et al., 2024), significant improvements in sleep quality and quantity (Cheah et al., 2021), and improvements in physical performance, strength, and recovery metrics (Bonilla et al., 2021; Nutrients 2026). While evidence for physical performance and body composition outcomes is derived from a smaller number of trials with moderate heterogeneity, published meta-analyses confirm the claimed benefits across strength, sleep, and stress management.
- supports: Effects of Ashwagandha ( Withania somnifera ) on Physical Performance: Systematic Review a… (Journal of functional morphology and kinesiology 2021) · cited 88x in the literature
"The meta-analytic approaches of the included studies revealed that Ashwagandha supplementation was more efficacious than placebo for improving variables related to physical performance in healthy men and female." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Effect of Ashwagandha (Withania somnifera) extract on sleep: A systematic review and meta-… (PloS one 2021) · cited 83x in the literature
"Ashwagandha extract exhibited a small but significant effect on overall sleep (Standardized Mean Difference -0.59; 95% Confidence Interval -0.75 to -0.42; I2 = 62%)." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Does Ashwagandha supplementation have a beneficial effect on the management of anxiety and… (Phytotherapy research : PTR 2022) · cited 73x in the literature
"We found that Ashwagandha supplementation significantly reduced anxiety (SMD: -1.55, 95% CI: -2.37, -0.74; p = .005; I 2 = 93.8%) and stress level (SMD: -1.75; 95% CI: -2.29, -1.22; p = .005; I 2 = 83.1%) compared to the placebo." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Effects of Ashwagandha (Withania Somnifera) on stress and anxiety: A systematic review and… (Explore (New York, N.Y.) 2024) · cited 31x in the literature
"The findings of the meta-analysis showed a significant effect of Ashwagandha formulations on the Perceived Stress Scale (PSS) (MD = -4.72, 95 % CI = [-8.45 to -0.99]), Hamilton Anxiety Scale (HAS) (MD = -2.19, 95 % CI = [-3.83 to -0.55]), and serum cortisol levels (MD = -2.58, 95 % CI = [-4.99 to -0.16]) compared to the placebo group." (abstract, results, passage verified)
pubmedfull study (doi)
Ashwagandha supplementation increases testosterone levels.
"It raises testosterone too, but not an amount that would—it doesn't raise the testosterone or lower cortisol enough to where it explains the changes in lean mass." (said at 3:22:33)
Randomized controlled trials and meta-analytic evidence demonstrate that ashwagandha (Withania somnifera) supplementation leads to modest but statistically significant increases in serum testosterone levels in men. A systematic review and meta-analysis of randomized placebo-controlled trials found that ashwagandha supplementation increased circulating testosterone in men by a mean difference of 57.43 ng/dL, while having no significant effect in women. Individual randomized trials in healthy, overweight, and resistance-training male cohorts have similarly reported modest increases in total testosterone (typically 14% to 17% above baseline or placebo). As the speaker noted, the magnitude of these hormonal shifts is modest.
- supports: Examining the effect of Withania somnifera supplementation on muscle strength and recovery… (Journal of the International Society of Sports Nutrition 2015) · cited 162x in the literature
"significantly greater increase in testosterone level (Placebo: 18.0 ng/dL, 95% CI, -15.8, 51.8 vs. Ashwagandha: 96.2 ng/dL, 95% CI, 54.7, 137.5; p = 0.004)" (abstract, results, passage verified)
pubmedfull study (doi) - supports: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Examining the Hormonal and… (American journal of men's health 2019) · cited 100x in the literature
"Ashwagandha intake was associated with an 18% greater increase in DHEA-S ( p = .005) and 14.7% greater increase in testosterone ( p = .010) compared to the placebo." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Hormonal Modulation with Withania somnifera: Systematic Review and Meta-Analysis of Random… (Planta medica 2026)
"Ashwagandha increased testosterone in men (MD = 57.43 ng/dl) but not in women (MD = 5.09 ng/dl), with a significant gender difference." (abstract, results, passage verified)
pubmedfull study (doi)
Beta-alanine supplementation provides performance benefits during high-intensity exercise lasting between 30 seconds and 10 minutes.
"You have things like beta-alanine, which if you're exercising like intense between 30 seconds and 10 minutes, that appears to have some benefits." (said at 3:23:34)
Systematic reviews and meta-analyses of double-blind, placebo-controlled randomized trials demonstrate that beta-alanine supplementation significantly improves high-intensity exercise outcomes, with the most pronounced ergogenic effects observed in exercise protocols lasting between 30 seconds and 10 minutes (0.5 to 10 minutes). Beta-alanine serves as a rate-limiting precursor to intramuscular carnosine, which buffers hydrogen ion accumulation during intense glycolytic exercise.
Citrulline supplementation at a dose of at least 6 grams improves fatigue resistance during exercise.
"Citrulline may have some benefits, at least if you're getting like 6 grams, in terms of like fatigue resistance." (said at 3:23:34)
Systematic reviews and meta-analyses of randomized controlled trials support that acute pre-exercise supplementation with citrulline (typically 6–8 grams of citrulline malate, providing approximately 3.5–6 g of L-citrulline) provides a small but statistically significant benefit for fatigue resistance during high-intensity resistance exercise, such as increasing the number of repetitions performed to failure. Meta-analyses report small pooled effect sizes (SMD ~0.20) for strength endurance and power tasks, as well as modest reductions in ratings of perceived exertion.
- supports: Acute Effects of Citrulline Supplementation on High-Intensity Strength and Power Performan… (Sports medicine (Auckland, N.Z.) 2019) · cited 71x in the literature
"Results of the meta-analysis identified a significant benefit for citrulline compared to placebo treatments (p = 0.036), with a small pooled standardized mean difference (SMD; Hedges' G) of 0.20 (95% confidence interval 0.01-0.39)." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Effect of citrulline on post-exercise rating of perceived exertion, muscle soreness, and b… (Journal of sport and health science 2020) · cited 59x in the literature
"The most frequent dosage used in the studies was 8 g of citrulline malate. Citrulline supplementation significantly reduced RPE (n = 7, p = 0.03) and muscle soreness 24-h and 48-h after post-exercise" (abstract, results, passage verified)
pubmedfull study (doi) - supports: Acute Effect of Citrulline Malate on Repetition Performance During Strength Training: A Sy… (International journal of sport nutrition and exercise metabolism 2021) · cited 43x in the literature
"Supplementing with 6-8 g of CitMal 40-60 min before exercise increased repetitions by 3 ± 5 (6.4 ± 7.9%) compared with placebo (p = .022) with a small SMD (0.196)." (abstract, results, passage verified)
pubmedfull study (doi)
Randomized controlled trials show that melatonin supplementation increases lean mass.
"Actually, melatonin has shown an increase in lean mass as well. ... there's some studies now, randomized controlled trials showing an increase in lean mass." (said at 3:24:04)
Randomized controlled trials have reported increases in lean mass following melatonin supplementation, though the evidence is limited to small trials in specific populations. In a double-blind, randomized placebo-controlled trial of 81 postmenopausal women over one year (PMID 26352863), melatonin supplementation resulted in a statistically significant increase in lean mass after adjusting for BMI (2.6%, p = 0.04), alongside a reduction in fat mass. Additionally, a randomized trial in patients with multiple sclerosis (PMID 42217742) found that combining melatonin with exercise training led to significantly greater increases in lean mass compared to exercise alone.
Harvard researchers published an internet survey examining self-reported health outcomes and symptom improvements in individuals consuming a carnivore diet.
"And then here comes this like internet survey that was published by Harvard about people—I think it was Harvard, but it was like a self-reported internet survey of people like reporting like certain things improving on carnivore diet." (said at 48:28:46)
Researchers from Boston Children's Hospital and Harvard Medical School (Lennerz et al., 2021) published an online cross-sectional survey of 2,029 adults following a carnivore diet for at least 6 months. Participants recruited via social media reported high satisfaction and widespread improvements in overall health (95%), well-being (66%–91%), and various medical conditions (48%–98%), alongside reductions in BMI and diabetes medication use. The authors noted that these observational self-reported findings are subject to recall and selection bias, with variable cardiovascular risk markers (such as markedly elevated LDL cholesterol), requiring further controlled investigation.
- supports: Behavioral Characteristics and Self-Reported Health Status among 2029 Adults Consuming a "… (Current developments in nutrition 2021) · cited 47x in the literature
"A social media survey was conducted 30 March-24 June, 2020 among adults self-identifying as consuming a carnivore diet for ≥6 mo. Survey questions interrogated motivation, dietary intake patterns, symptoms suggestive of nutritional deficiencies or other adverse effects, satisfaction, prior and current health conditions, anthropometrics, and laboratory data... Participants reported high levels of satisfaction and improvements in overall health (95%), well-being (66%-91%), various medical conditions (48%-98%), and median [IQR] BMI" (abstract, methods and results, passage verified)
pubmedfull study (doi)
Fact-checked episodes
Publications